A $60 billion arms sale to Saudi Arabia — the largest in U.S. history — is poised to proceed despite questions raised by some members of Congress. In a November 16 letter to Congress (pdf), Secretary of Defense Robert Gates and Secretary of State Hillary Clinton defended the deal:
“This proposed sale will directly support U.S. interests by reinforcing our longstanding defense and security partnership with Saudi Arabia, enhancing Saudi Arabia’s ability to deter and defend itself against terrorist groups and other regional threats, improving interoperability with the U.S. military, and sending a strong message to all countries that the United States is committed to supporting the security of its key partners and allies in the Gulf and broader Middle East,” they wrote.
Members of Congress had written to the Administration on November 12 (pdf) “to raise concerns and pose a number of strategic questions about the impact such sales would have on the national security interests of the United States and our allies.” The Gates-Clinton letter was written in response.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.